1. Restenosis: The Clinical Problem; A.D. Simon, et al. 2. The Pathobiology of Restenosis. A Paradigm from Clinical and Experimental Studies; J.L. Januzzi, E.R. Edelman. 3. Coronary Repair and Restenosis. Cellular Basis for Antisense Approaches; A. Zalewski, et al. 4. Vascular Smooth Muscle Cell Biology and Restenosis; J.A. Leopold, J. Loscalzo. 5. Vascular Antisense Therapy Directed Against c-myc, c-myb, and PCNA; M. Husain, M. Simons. 6. Phosphorothioate Oligodeoxynucleotides as Inhibitors of Gene Expression: Antisense and Non-Antisense Effects; I.V. Lebedeva, C.A. Stein. 7. Molecular Therapies for Vascular Disease: Altering the Balance Between Cell Growth and Cell Death; G.H. Gibbons. 8. Oligonucleotides Containing the G-Quartet Sequence Motif; J.R. Wyatt, C.A. Stein. 9. Non-G-Quartet, Non-Sequence Specific Antirestonitic Effects of Phosphorothioate Oligodeoxynucleotides; L.E. Rabbani, et al. 10. Local Delivery of Antirestenotic Drugs; D.E. Drachman, et al. 11. Critical Considerations and Future Directions; M.R. Bennett, S.M. Schwartz.Springer Book Archives